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Abstract
Background: Fish gonadal sex differentiation is affected by sex steroids treatments providing an
efficient strategy to control the sexual phenotype of fish for aquaculture purposes. However, the
biological effects of such treatments are poorly understood. The aim of this study was to identify
the main effects of an androgen masculinizing treatment (11β-hydroxyandrostenedione, 11βOH∆4,
10 mg/kg of food for 3 months) on gonadal gene expression profiles of an all-female genetic
population of trout. To characterize the most important molecular features of this process, we
used a large scale gene expression profiling approach using rainbow trout DNA microarrays
combined with a detailed gene ontology (GO) analysis.
Results:  2,474 genes were characterized as up-regulated or down-regulated in trout female
gonads masculinized by androgen in comparison with control male or female gonads from
untreated all-male and all-female genetic populations. These genes were classified in 13 k-means
clusters of temporally correlated expression profiles. Gene ontology (GO) data mining revealed
that androgen treatment triggers a marked down-regulation of genes potentially involved in early
oogenesis processes (GO 'mitotic cell cycle', 'nucleolus'), an up-regulation of the translation
machinery (GO 'ribosome') along with a down-regulation of proteolysis (GO 'proteolysis',
'peptidase' and 'metallopeptidase activity'). Genes considered as muscle fibres markers (GO
'muscle contraction') and genes annotated as structural constituents of the extracellular matrix
(GO 'extracellular matrix') or related to meiosis (GO 'chromosome' and 'meiosis') were found
significantly enriched in the two clusters of genes specifically up-regulated in androgen-treated
female gonads. GO annotations 'Sex differentiation' and 'steroid biosynthesis' were enriched in a
cluster of genes with high expression levels only in control males. Interestingly none of these genes
were stimulated by the masculinizing androgen treatment.
Conclusion: This study provides evidence that androgen masculinization results in a marked
dysregulation of early gene expression profiles when compared to natural testicular or ovarian
differentiation. Based on these results we suggest that, in our experimental conditions, androgen
masculinization proceeds mainly through an early inhibition of female development.
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Background
The embryonic gonad has the potential to develop into a
fully functional organ able to produce the gametes neces-
sary for sexual reproduction. Sex differentiation is a cru-
cial step in this developmental process and is considered
as the differentiation from a bipotential gonadal primor-
dium towards a testis or an ovary. In teleostean fish, sex
differentiation can be controlled by in vivo treatments
with sex steroids (reviewed in [1]) as in reptiles and
amphibians and to some extent in birds (reviewed in [2-
4]). In fish, these steroid treatments are often able to
induce fully functional sex-inversed phenotypes and these
treatments have been widely used to produce all-male or
all-female populations of fish for aquaculture purposes
[5]. Many studies have been focused on the role of these
hormones during gonadal sex differentiation highlighting
for instance the crucial role of estrogens in ovarian differ-
entiation [1]. However, most of the studies performed
thus far were focused on a very small number of well char-
acterized genes, proteins or hormones and mostly on nat-
ural gonadal differentiation.
Rainbow trout, Oncorhynchus mykiss, has a male heteroga-
metic XY genetic system and we experimentally produced
XX and YY males allowing the production of genetically
all-male and all-female populations [6]. These all-male or
all-female populations provide a unique opportunity to
work on numerous animals for which the normal gonadal
development as testis or ovary is known a priori. Using the
extensive collection of expressed sequenced tags (ESTs)
obtained through sequencing projects in trout as a
resource [7,8], we designed and built a DNA microarray in
order to characterize, on a genome-wide scale, the mech-
anisms by which 11β-hydroxyandrostenedione
(11βOH∆4), a natural androgen in fish [9,10] is able to
masculinize the embryonic ovary.
Using this genome-wide approach we characterized 2,474
genes (2372 microarray and 102 real-time RT-PCR gene
expression profiles) with a clear differential temporal
expression profile in females masculinized by androgen.
We classified these genes in 13 different clusters of corre-
lated temporal expression profiles, and searched within
these clusters for significant enrichment in Gene Ontol-
ogy (GO) terms. This strategy allowed us to define a few
very clear biological trends potentially explaining how
androgen induces masculinization of female fish. Our
results clearly demonstrate that masculinization with
androgen proceeds through a marked dysregulation of
gene expression profiles, including a quick down-regula-
tion of the ovarian pathway. Surprisingly, most of the
genes over-expressed during natural testicular differentia-
tion were not restored by the androgen-induced masculi-
nization suggesting that the inhibition of female gonadal
development is the main required step sufficient for
building a testis.
Results
The complete dataset is available through the National
Center for Biotechnology Information (NCBI), in the
Gene Expression Omnibus database [11] under the
GSE7018 accession number. After statistical filtering,
2,474 expression profiles (2372 microarray and 102 real-
time RT-PCR gene expression profiles, data available as
supplemental material in Additional file 1) were identi-
fied as being characteristic for either natural differentia-
tion (ovarian or testicular differentiation) or androgen-
induced masculinization (trans-differentiating gonads).
Among these 2,474 expression profiles, 73% (1,805) were
associated with genes with significant homologies with
well characterized proteins in Swissprot or Prodom data-
bases (the complete list of clones and their annotations is
available as supplemental material in Additional file 2).
Biological sample clustering and histology
This analysis was carried out on fish sampled at several
stages of development from the onset of the free swim-
ming period (Day 0 = D0), when fish first started to be fed
with the androgen treatment until 110 days after the
beginning of the treatment (D110). Unsupervised hierar-
chical clustering of samples (Fig 1A) reveals 3 main
groups of correlated samples according to their global
gene expression profiles i.e., late ovarian samples (D60 to
D110, correlation coefficient R = 0.78), middle and late
gonad samples of androgen-treated fish gonads (D27 to
D110, R = 0.37) and middle and late testicular samples
(D27 to D110, R = 0.26). All early samples (D0 to D12)
cluster together with a weak correlation (R = 0.07), indi-
cating that differences in the expression profiles of these
early samples are rather large. Histological analysis of
gonads at D12 (Fig. 1B, panels a, c, e) reveals characteristic
features of differentiating gonads in control fish with the
first appearance of ovarian meiosis and lamellar structures
in females, or spermatogonia cysts in males. At this time-
point (D12), gonads of androgen-treated females appear
as a thin structure characterized by scattered germ cells in
a predominant stroma of conjunctive tissue with fibrob-
last like cells. After 90 days of treatment (Fig. 1B, panels b,
d, f) the gonads of androgen-treated females display a
classical testicular organization with cysts of germ cells
engaged at various stages of meioses whereas the control
male gonads show the same organization but with only
gonial mitosis. At D90, the control female gonads contain
previtellogenic oocytes surrounded by flattened granulosa
cells and oogonia within clearly organized ovarian lamel-
lae.BMC Genomics 2007, 8:357 http://www.biomedcentral.com/1471-2164/8/357
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Global analysis of gene expression profiles
The 2,474 expression profiles were analyzed using a k-
means clustering (with k = 13) in order to individualize
clusters of genes with similar expression profiles (Fig. 2).
These expression profiles and the 13 k-means clusters are
available online as a browseable file [12]. Among these
clusters, clusters 1 to 4 are characterized by a specific high
expression levels of a very large number of genes (N =
1,204) specific to the late ovarian samples (D60 to D110).
These clusters could have been merged as their expression
profiles seem very similar. In cluster 5 (N = 184) these
high expression levels in the female group after D60 are
also present in the androgen-treated group after D27.
Cluster 6 (N = 89) contains genes with increasing expres-
sion profiles starting from D16 in androgen-treated
females and from D27 in control males. Clusters 7 (N =
132) and 8 (N = 77) are characterized by an early (starting
from D27, cluster 7) or late (starting from D90, cluster 8)
increase in gene expression specific to the androgen-
treated females. Genes in cluster 9 (N = 214) display a late
down-regulation starting from D60 in control female
gonads. Cluster 10 (N = 133) is the only cluster that does
not show any difference between males, females and
androgen-treated females and contains genes with contin-
uously decreasing expression levels from D0 to D110.
Cluster 11 (N = 172) contains genes down-regulated both
in females (from D60) and androgen-treated females
(from D27). Cluster 12 (N = 214) is characterized by gene
Classification of gonad samples and histological analysis of some characteristic gonadal stages Figure 1
Classification of gonad samples and histological analysis of some characteristic gonadal stages. (A) Dendrogram 
of the samples ranked using a hierarchical clustering. Gonad samples are colorized according to the sex i.e., red for females, 
blue for males and black for androgen-treated females. Correlation coefficients (R) of the last branches of a cluster are given. 
(B) Histology of the gonads from the female control group (a, b), the androgen-treated group (c, d), and the male control 
group (e, f) at 12 days (D12) and 90 days (D90) after the beginning of the androgen treatment. BV: blood vessel; FC: fibroblast 
like cell; Go (A1/A2/B): gonia type (A1/A2/B); I: Interstitial space; M: mitosis; Me: meiosis; N: nucleus; n: nucleolus; OV: ovo-
cyte; P: pachytene stage of meiosis; (p)G: (pre)granulosa cell ; (p)S: (pre)sertoli cell ; Spc(I/II): spermatocyte I/II; Spt: spermatid; 
Str: ovarian stroma.
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expression levels specifically down-regulated (from D27)
in androgen-treated females. However, this down-regula-
tion is not maintained after the end of the treatment (i.e.
after D90). Cluster 13 is the smallest cluster in terms of
the number of genes (N = 55) and it displays high expres-
sion levels specifically in males throughout all the sam-
pling times (from D0 to D110). Expression levels in
androgen-treated females slightly increase after comple-
tion of the treatment (> D90).
Annotation of gene clusters using Gene Ontology (GO)
We then searched for Gene ontology (GO) terms signifi-
cantly enriched in these groups of correlated expression
profiles compared to the overall GO terms found. Among
the 1,805 genes with an annotation we selected 1,276
unique genes annotated with an official name, and 1,133
were found to be associated with at least one GO category.
The top 5 significantly enriched GO terms for each of the
clusters are described in Table 1 and 2 and the complete
analysis is available online (as supplemental material in
Additional file 3).
As gene expression in clusters 1 to 5 displayed similar
expression profiles in the control female group, these clus-
ters have been analysed both all together and separately
(Table 1). If considered as a homogenous cluster it dis-
plays considerable enrichments in GO terms likely to be
important characteristics of these late ovarian stages.
Among these GO terms the most representatives (see
Table 1 and Additional file 3) are the 'regulation of pro-
gression through cell cycle' (GO ID 74) [including
'mitotic cycle' (ID 278)], the 'macromolecule biosynthe-
sis' (ID 9059) [including 'protein biosynthesis' (ID 6412)]
and the cellular component ontology 'nucleolus' (ID
Gene expression profiles following androgen treatment in female rainbow trout Figure 2
Gene expression profiles following androgen treatment in female rainbow trout. (A) Heat map of the 2,474 differ-
entially expressed genes in rainbow trout gonads following androgen treatment. The 40 biological samples are ordered accord-
ing to the experimental groups (red for females; blue for males; black for androgen-treated females) and to the developmental 
stage (D0 to D110 from left to right). (B) Relative median gene profile of the 13 clusters of temporally correlated gene expres-
sion profiles.
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5730, see figure 3 for a detailed composition of this GO
term). GO term 'mitosis' (ID 7067) is highly over-repre-
sented in cluster 3 (see Table 1 and figure 4 for a detailed
composition of this GO term) with a 2.1 fold relative
enrichment (p value of 4.10-3). Among clusters 1 to 5,
only genes from cluster 5 are also highly expressed in the
androgen-treated group. The main GO theme of cluster 5
is related to translation, with over-representation of GO
'ribosome' (ID 5840, see figure 5 for a detailed composi-
tion of this GO term), 'ribonucleoprotein complex' (ID
30529), and 'ribosome biogenesis and assembly' (ID
42254). Within the GO term 'ribosome', a large propor-
tion of genes (7 out of 13) up-regulated in cluster 5 are
also annotated as 'cytosolic large ribosomal subunit' (ID
5842, e.g. rpl5, rpl7, rpl13a, rpl17, rpl19 and rpl21, see
Fig. 5). Cluster 6 contains genes that are up-regulated both
in control males and androgen-treated females. It con-
tains genes (Table 2) involved in 'cell surface' (ID 9986),
'T cell activation' (ID 42110) and the 'immune response'
(ID 6955). Clusters 7 and 8 are of particular interest as
they display an up-regulation only in androgen-treated
females. Cluster 7 is characterized by the GO terms 'extra-
cellular matrix' (ID 5578), 'actin binding' and 'muscle
contraction' (ID 3779 and ID 6936) including genes like
myosins (e.g. myl6 and myl11), tropomyosins (e.g. tpm1,
tpm3 and tpm4) and some muscle markers (e.g.
calponin2, cnn2 and transgelin, tagln). The GO term
'extracellular matrix' (Fig. 6) contains 30 different genes,
and 10 are specifically up-regulated in cluster 7 following
androgen treatment in females (4.6 fold enrichment with
a p value < 4.10-4). Many of these genes (e.g. col1a1,
col1a2, col6a2, and mfap2), are 'structural constituents of
the extracellular matrix' (ID 5201), or are involved in 'cell
adhesion' (ID 7155) (e.g. col6a2, sparc and postn). The
expression profiles of some of these genes related to the
extracellular matrix are shown in figure 7 along with the
tgfb1 expression profile that also shows a slight up-regu-
lation from D60 to D110 following androgen treatment
Table 1: The top 5 most significant Gene Ontology (GO) terms significantly enriched in K-means clusters 1 to 5
KM Term (GO ID) P-Value RE (n/N)
1 to 5 regulation of progression through cell cycle (74) 0.0002 1.36 (50/62)
nucleolus (5730) 0.0012 1.49 (23/26)
mitotic cell cycle (278) 0.0016 1.37 (35/43)
macromolecule biosynthesis (9059) 0.0029 1.22 (74/102)
protein biosynthesis (6412) 0.0031 1.23 (68/93)
1 cytoplasmic membrane-bound vesicle (16023) 0.0063 3.00 (7/25)
telomere maintenance (723) 0.0071 6.40 (3/5)
ion homeostasis (50801) 0.0095 3.50 (5/15)
gastrulation (7369) 0.0147 3.90 (4/11)
digestion (7586) 0.0216 4.50 (3/7)
2 cellular respiration (45333) 0.0000 5.90 (7/8)
translation regulator activity (45182) 0.0000 3.20 (13/27)
aerobic respiration (9060) 0.0001 6.70 (5/5)
pyrophosphatase activity (16462) 0.0004 2.10 (21/68)
GTPase activity (3924) 0.0012 2.80 (10/24)
3 mitosis (7067) 0.0040 2.10 (12/26)
rRNA binding (19843) 0.0064 3.30 (5/7)
nuclear hormone receptor binding (35257) 0.0088 3.70 (4/5)
replication fork (5657) 0.0141 2.90 (5/8)
interphase of mitotic cell cycle (51329) 0.0154 2.10 (9/20)
4 hydrogen-transporting ATPase activity (46961) 0.0009 4.20 (6/10)
ATP biosynthesis (6754) 0.0018 3.90 (6/11)
cell growth (16049) 0.0053 3.30 (6/13)
transcription factor binding (8134) 0.0094 2.20 (10/32)
chromatin assembly (31497) 0.0169 3.50 (4/8)
5 ribosome (5840) 0.0000 3.40 (18/48)
ribonucleoprotein complex (30529) 0.0000 2.70 (26/88)
cytoplasm organization and biogenesis (7028) 0.0003 2.90 (12/37)
cytosolic large ribosomal subunit (5842) 0.0005 4.90 (6/11)
ribosome biogenesis and assembly (42254) 0.0006 2.90 (11/34)
These GO terms were selected as the 5 most significant GO terms enriched in each K-means cluster (KM) 1 to 5 with a P-value < 0.05 and a 
relative enrichment RE > 2 (except for the analysis of the fusion of clusters 1 to 5). n/N: number of genes assigned with a specific GO term in the 
cluster (n) with regards to the number of all genes assigned with the same GO term in the 2,474 analyzed genes (N). Interesting GO terms in 
regard to gonad differentiation and development are underlined. Genes with GO terms in bold type are detailed in figures 3 to 5. GO categories 
containing fewer than 5 genes were excluded.BMC Genomics 2007, 8:357 http://www.biomedcentral.com/1471-2164/8/357
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in females. Cluster 8 contains genes related to 'chromo-
some' (ID 5694), 'condensed chromosome' (ID 793) but
also, albeit only a few (2 out of 6), to the 'progression
through the first phase of meiosis' ('meiosis I', ID 7126,
i.e., rad1 and the synaptonemal complex central element
protein 2, syce2). Cluster 9 is characterized by enrichment
in the GO terms 'organ morphogenesis' (ID 9887), 'devel-
opment' (ID 48513) and 'structural constituent of
cytoskeleton' (ID 5200). Cluster 10 contains genes
involved in 'urogenital system development' (ID 1655)
and 'lipid binding' (ID 8289). Clusters 11 and 12 contain
genes that are also assigned with the GO term 'extracellu-
lar matrix' but more specifically in relation with degrada-
tion of this extracellular matrix i.e., GO term
'metallopeptidase' (5.4 and 3.8 fold enrichment respec-
tively) with at least 3 matrix metallopeptidases (e.g.
mmp13, mmp14, mmp19) that are directly involved in
'collagen catabolism' (ID 30574). Cluster 13 contains
genes related to 'sex differentiation' (ID 7548) (e.g. amh,
sox9, dmrt1, gata4, lhx9), and 'steroid biosynthesis' (ID
6694) (e.g. cyp17a1, cyp11b2, star and nr5a2). According
to these annotations this cluster is likely to contain other
Table 2: The top 5 most significant Gene Ontology (GO) terms significantly enriched in K-means clusters 6 to 13
KM Term (GO ID) P-Value RE (n/N)
6 cell surface (9986) 0.0000 12.30 (5/11)
T cell activation (42110) 0.0005 16.20 (3/5)
immune response (6955) 0.0015 4.50 (6/36)
lipid binding (8289) 0.0020 5.20 (5/26)
neuron development (48666) 0.0022 6.70 (4/16)
7 extracellular matrix (sensu Metazoa) (5578) 0.0000 4.60 (10/32)
actin binding (3779) 0.0002 4.50 (8/26)
muscle contraction (6936) 0.0004 6.70 (5/11)
phosphate transport (6817) 0.0006 8.40 (4/7)
structural molecule activity (5198) 0.0012 2.30 (15/96)
8 condensed chromosome (793) 0.0005 15.50 (3/5)
response to endogenous stimulus (9719) 0.0025 5.00 (5/26)
DNA repair (6281) 0.0061 5.20 (4/20)
magnesium ion binding (287) 0.0087 4.70 (4/22)
chromosome (5694) 0.0224 3.00 (5/43)
9 calcium ion binding (5509) 0.0004 2.50 (15/63)
organ morphogenesis (9887) 0.0006 2.60 (13/52)
plasma membrane (5886) 0.0011 2.10 (18/90)
organ development (48513) 0.0018 2.10 (16/79)
structural constituent of cytoskeleton (5200) 0.0020 4.80 (5/11)
10 urogenital system development (1655) 0.0060 7.00 (3/6)
lipid binding (8289) 0.0080 3.20 (6/26)
response to temperature stimulus (9266) 0.0100 6.00 (3/7)
protein kinase binding (19901) 0.0100 6.00 (3/7)
circulation (8015) 0.0152 5.20 (3/8)
11 metallopeptidase activity (8237) 0.0013 5.40 (5/12)
proteolysis (6508) 0.0016 2.40 (13/69)
peptidase activity (8233) 0.0022 2.50 (12/63)
endopeptidase activity (4175) 0.0079 2.50 (9/47)
transcription from RNA polymerase II promoter (6366) 0.0381 2.00 (8/51)
12 ligase activity, forming carbon-nitrogen bonds (16879) 0.0050 3.00 (7/21)
metallopeptidase activity (8237) 0.0061 3.80 (5/12)
mRNA metabolism (16071) 0.0165 2.10 (10/44)
glutamine family amino acid biosynthesis (9084) 0.0200 4.60 (3/6)
regulation of RNA metabolism (51252) 0.0322 3.90 (3/7)
13 steroid biosynthesis (6694) 0.0020 10.80 (3/9)
sex differentiation (7548) 0.0028 9.70 (3/10)
transcription, DNA-dependent (6351) 0.0050 2.30 (11/156)
hormone metabolism (42445) 0.0063 7.50 (3/13)
DNA binding (3677) 0.0071 2.20 (11/163)
These GO terms were selected as the 5 most significant GO terms enriched in each K-means cluster (KM) 6 to 13 with a P-value < 0.05 and a 
relative enrichment RE > 2. n/N: number of genes assigned with a specific GO term in the cluster (n) with regards to the number of all genes 
assigned with the same GO term in the 2,474 analyzed genes (N). Interesting GO terms in regard to gonad differentiation and development are 
underlined. Genes with GO terms in bold type are detailed in figure 6. GO categories containing fewer than 5 genes were excluded.BMC Genomics 2007, 8:357 http://www.biomedcentral.com/1471-2164/8/357
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important genes also involved in testicular differentiation
or in steroidogenesis regulation. Several expression pro-
files for such potential genes are shown in figure 8.
Validation and enrichment of DNA microarray data by 
real-time RT-PCR
Expression profiles of 102 genes, involved in early gonad
development, were measured by real-time RT-PCR. These
genes all belonged to the 13 distinct k-means clusters (see
Additional file 1). Among these 102 genes, 84 were only
measured by real-time RT-PCR and these gene expression
profiles were thus added to the microarray dataset. The
remaining 18 genes were common between the real-time
RT-PCR dataset and the microarray dataset (see Table 3)
and were used to validate our microarray dataset. Among
the 18 common genes belonging to 11 out of the 13 dis-
tinct k-means clusters (e.g. 1, 2, 3, 4, 5, 6, 8, 9, 10, 11, and
13), 15 expression profiles were found to have a signifi-
cant correlation between the two techniques (see Table 3
and Fig. 9). Only tfa (transferrin), timp2 (tissue inhibitor of
metalloproteinase 2) and bzrp  (benzodiazepine receptor,
peripheral) expression profiles did not significantly corre-
late. As a result, among the 13 k-means groups, at least 10
groups (e.g. 1, 2, 3, 4, 5, 6, 8, 9, 11, and 13) contained
genes with significant correlation between real-time RT-
PCR and DNA microarray measurements.
Discussion
Our global approach based on gene expression profiling
clearly reveals that, in our experimental conditions
(11βOH∆4, 10 mg/kg of food for 3 months), the andro-
gen masculinization does not induce a natural physiolog-
ical response since the transcriptome of testicular trans-
differentiating gonads is quite different from the one
observed during natural testicular differentiation. These
differences might be due to the non physiological dosage
of androgen used in our experiment. A similar study using
a lower dosage may help to clarify this issue, but this study
Expression profiles of genes belonging to the Gene Ontology term "nucleolus" (ID 5730) Figure 3
Expression profiles of genes belonging to the Gene Ontology term "nucleolus" (ID 5730). Clones with similar gene 
names that belong to the same contig (ensemble of clones with overlapping sequences) but displayed very different expression 
profiles were excluded from the table (when the expression profiles were not too different the gene symbol are marked with 
an asterisk). Clones with similar gene names and belonging to different contigs were annotated as gene symbol_1 and gene 
symbol_2 as they could be considered as potentially duplicated genes or differential splicing forms. KM: K-means cluster 
number. N: number of genes belonging to the GO term in the specified cluster.
1 6 tcav0002.h.20 rnu3ip2_1  RNA, U3 small nucleolar interacting protein 2
    tcad0001.j.22  orf2  Probable RNA-directed DNA polymerase from transposon X-element
   tcad0004.f.08  znf259   zinc finger protein 259   
   tcac0001.m.03  eif3s6ip  eukaryotic translation initiation factor 3, subunit 6 interacting protein  
   tcad0009.k.16  unc84a  unc-84 homolog A (C. elegans) 
      tcad0007.f.01  rrn3   RRN3 RNA polymerase I transcription factor homolog (yeast)  
2  6 tcav0003.c.15  exosc4    exosome component 4 
tcav0005.d.02  rnu3ip2_2  RNA, U3 small nucleolar interacting protein 2 
 tcav0005.n.01  snrpd2  small nuclear ribonucleoprotein D2 polypeptide 16.5kDa 
 tcad0005.f.24  senp3    SUMO1/sentrin/SMT3 specific protease 3 
tcac0005.a.15  nhp2l1_1  NHP2 non-histone chromosome protein 2-like 1 (S. cerevisiae) 
   tcab0002.g.10  ilf2   interleukin enhancer binding factor 2, 45kDa 
3 5  tcad0005.j.24 nol5a   nucleolar protein 5A  
   tcad0004.a.09  gnl3  Guanine nucleotide-binding protein-like 3 
   tcac0003.g.11  nola2   nucleolar protein family A, member 2 (H/ACA small nucleolar RNPs)   
   tcad0007.o.22  nhp2l1_2*   NHP2 non-histone chromosome protein 2-like 1 (S. cerevisiae) 
   tcab0003.b.22  rpl12*  ribosomal protein L12 
4 1  tcac0004.b.05  nhp2l1_2*   NHP2 non-histone chromosome protein 2-like 1 (S. cerevisiae) 
5 8  tcad0007.e.18  snrpd3  Small nuclear ribonucleoprotein Sm D3 
   tcad0004.e.22  rps5_1   ribosomal protein S5  
   tcad0005.n.07  rps5_2   ribosomal protein S5  
   tcav0004.a.08  mphosph1   M-phase phosphoprotein 1  
   tcac0001.i.01 rps2   ribosomal protein S2 
   tcad0006.g.01  rpl12*   ribosomal protein L12 
   tcac0003.i.01 rpa2   replication protein A2 
      tcav0005.d.20  nme1   non-metastatic cells 1, protein (NM23A) 
6 1  tcad0004.h.09  lsm7   LSM7 homolog, U6 small nuclear RNA associated (S. cerevisiae)    
11  1  tcad0009.m.04 gar2  Protein gar2 (S. pombe) 
12  1 tcad0006.g.14  snrpd1   small nuclear ribonucleoprotein D1 polypeptide  1
Fe Females males M Males ales F.11 F.11β β β β β β β β KM  N     Clone name    Symbol          Gene Name
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was first designed with an androgen dosage that is com-
monly used in rainbow trout aquaculture conditions.
Whether the observed gene expression dysregulations are
the reflection of a direct action of the androgens on the
gonad, an indirect retro-control on the hypothalamus-
pituitary axis, or a conjunction of both, remains to be elu-
cidated. However, the synthesis of Gonadotropin Releas-
ing Hormone (GnRH) and of pituitary hormones is
established very early during rainbow trout ontogenesis
[13] with at least the synthesis of Follicle Stimulating Hor-
mone FSH [14]. Thus indirect feedback effects cannot be
totally excluded.
Due to the lack of specific Gene Ontology (GO) annota-
tion for rainbow trout we linked the best blast hits of each
clone sequence with a cross-species GO annotation. This
strategy relies on the accuracy of the blast homology
search and also on the resulting accuracy of the GO anno-
tations with regards to their use in a fish species. However,
even if this could lead to potential errors on a gene per
gene scale, the global analysis and stringent statistical
screen that we carried out enabled us to unambiguously
assign most clusters with a clear biological theme. Among
these GO categories, some were considered as biologically
informative – i.e., not too general like for instance GO
"physiological process" – and robust as they contain a suf-
ficient number of different genes to support a potential
biological meaning. We focused our analysis on these bio-
logically informative GO categories.
With regards to the effects on the gonad, our analysis first
reveals that female development is highly affected by the
androgen treatment, with a down-regulation of most of
the genes involved in early oogenesis stages. However
within this analysis we did not characterize any cluster of
early female-specific up-regulated genes potentially
Expression profiles of genes belonging to the Gene Ontology term "mitosis" (ID 7067) Figure 4
Expression profiles of genes belonging to the Gene Ontology term "mitosis" (ID 7067). Clones with similar gene 
names that belong to the same contig (ensemble of clones with overlapping sequences) but displayed very different expression 
profiles were excluded from the table (when the expression profiles were not too different the gene symbol are marked with 
an asterisk). Clones with similar gene names and belonging to different contigs were annotated as gene symbol_1 and gene 
symbol_2 as they could be considered as potentially duplicated genes or differential splicing forms. KM: K-means cluster 
number. N: number of genes belonging to the GO term in the specified cluster.
1
  
2
3
  
4
5
  
6
  
8
9
Females Females Males Males F.11 F.11β β KM N Clone name Gene Symbol
3 
  
3 
12 
  
4 
3 
  
2 
1 
1 
BX077744 
tcac0001.h.17 
tcac0006.n.11 
tcad0007.l.19 
tcab0003.f.11 
tcad0009.b.14 
tcav0002.o.10 
tcab0003.p.14 
tcac0004.l.12 
tcad0007.c.12 
tcab0003.c.01 
tcab0003.j.11 
tcad0007.p.09 
tcad0008.a.04 
tcab0003.n.03 
tcac0004.d.24 
tcab0002.d.21 
tcav0004.h.04 
tcad0008.i.04 
tcab0002.d.22 
tcav0003.f.15 
tcav0004.a.08 
tcad0003.h.05 
tcav0005.h.01 
tcab0001.a.07 
tcad0005.g.18 
tcav0004.g.11 
cdh1 
rcc2* 
txnl4a 
cnp 
kif22 
cdc20 
cdc6 
ccnb1 
ccnb2 
katna1 
pttg1 
rps6ka2 
sssca1 
smu1* 
tpx2 
ube2c_1 
bub1b 
prmt5 
smu1* 
rcc2* 
cdca3 
mphosph1 
ube2c_2 
mapre3 
stag2 
cetn2 
No symbol 
Cadherin 1, type 1, E-cadherin (epithelial) 
Telophase disk protein of 60 kDa 
Thioredoxin-like protein 4A 
2',3'-cyclic nucleotide 3' phosphodiesterase  
Kinesin family member 22 
CDC20 cell division cycle 20 homolog 
CDC6 cell division cycle 6 homolog 
G2/mitotic-specific cyclin-B1 
G2/mitotic-specific cyclin-B2 
Katanin p60 ATPase-containing subunit A1 
Pituitary tumor-transforming 1  
Ribosomal protein S6 kinase alpha-2 
Sjoegren syndrome/scleroderma autoantigen 1 
Smu-1 suppressor of mec-8 and unc-52 homolog 
Targeting protein for Xklp2 
Ubiquitin-conjugating enzyme E2 C 
BUB1 budding uninhibited by benzimidazoles 1 homolog beta 
Protein arginine N-methyltransferase 5 
Smu-1 suppressor of mec-8 and unc-52 homolog 
Telophase disk protein of 60 kDa 
Cell division cycle associated 3 
M-phase phosphoprotein 1    
Ubiquitin-conjugating enzyme E2 C 
Microtubule-associated protein, RP/EB family, member 3 
Stromal antigen 2 
Centrin, EF-hand protein, 2 
Histone H5A 
11 11
2 
Gene Name
Gene Ontology “mitosis” (ID 7067) Gene Ontology “mitosis” (ID 7067) -1 +1BMC Genomics 2007, 8:357 http://www.biomedcentral.com/1471-2164/8/357
Page 9 of 18
(page number not for citation purposes)
involved in ovarian differentiation. Expression profiles of
some female-specific candidate genes [15] (e.g. foxl2a and
foxl2b, cyp19a1, fst, inha) were introduced in our analysis
and all these genes were strongly and quickly inhibited by
the masculinizing androgen treatment. But when pooled
with our DNA microarrays dataset they did not form a
tight cluster. This is probably because no additional simi-
lar expression profile was found within the DNA microar-
ray dataset. This very small number of early female-
specific genes is in agreement with the small number of
candidate genes known to be involved in the ovarian dif-
ferentiation pathway [16] in comparison with the rela-
tively high number of genes that are known to
characterize testicular differentiation [17]. In agreement
with this view, our analysis clearly characterizes a cluster
displaying testicular-specific gene expression profiles,
Expression profiles of genes belonging to the Gene Ontology term "ribosome" (ID 5840) Figure 5
Expression profiles of genes belonging to the Gene Ontology term "ribosome" (ID 5840). Clones with similar gene 
names that belong to the same contig (ensemble of clones with overlapping sequences) but displayed very different expression 
profiles were excluded from the table (when the expression profiles were not too different the gene symbol are marked with 
an asterisk). Clones with similar gene names and belonging to different contigs were annotated as gene symbol_1 and gene 
symbol_2 as they could be considered as potentially duplicated genes or differential splicing forms. KM: K-means cluster 
number. N: number of genes belonging to the GO term in the specified cluster.
1 1 tcad0001.n.08  mrpl14   mitochondrial ribosomal protein L14 
2 5 tcav0002.e.18  eif2s2_1   eukaryotic translation initiation factor 2, subunit 2 beta
  tcav0005.a.18  mrpl34   mitochondrial ribosomal protein L34 
  tcac0005.c.10  mrps18a   mitochondrial ribosomal protein S18A 
  tcab0001.i.08  rps18   ribosomal protein S18 
  tcad0005.h.01  rps4  ribosomal protein S4 
3 6 tcav0002.h.10  mrpl20   mitochondrial ribosomal protein L20 
  tcac0002.l.10  mrpl49   mitochondrial ribosomal protein L49 
  tcac0003.g.11  nola2   nucleolar protein family A, member 2 
  tcab0003.p.10  rpl30   ribosomal protein L30 
  tcad0009.k.22  rpl5_1  ribosomal protein L5 
      tcab0001.b.04  rps23  ribosomal protein S23 
4 7 tcav0003.c.07  mrpl17   mitochondrial ribosomal protein L17 
  tcav0002.i.11  mrpl48   mitochondrial ribosomal protein L48 
  tcab0002.o.12  rpl13a_1   ribosomal protein L13a 
  tcab0003.e.01  rpl18   ribosomal protein L18 
  tcac0001.o.22  rpl18a   ribosomal protein L18a 
  tcab0002.h.21  rpl35a   ribosomal protein L35a 
  tcac0005.n.06  rps2  ribosomal protein S2 
5 13 tcav0001.n.14  eif2s2_2   eukaryotic translation initiation factor 2, subunit 2 beta
  tcad0001.p.17  mrps15   mitochondrial ribosomal protein S15 
  tcac0003.i.01  rpa2   replication protein A2 
  tcac0004.o.12  rpl13a_2   ribosomal protein L13a 
  tcav0001.a.12  Rpl17   ribosomal protein L17 
  tcad0009.m.03  rpl19_1   ribosomal protein L19 
  tcad0007.h.22  rpl19_2   ribosomal protein L19 
  tcav0003.a.12  rpl21   ribosomal protein L21  
  tcad0004.g.16  rpl5_2  ribosomal protein L5 
  tcad0007.p.01  rpl7   ribosomal protein L7 
  tcac0001.i.01  rps2   ribosomal protein S2 
  tcad0004.e.22  rps5_1   ribosomal protein S5 
      tcad0005.n.07  rps5_2   ribosomal protein S5 
7 5 tcad0005.o.11  mrps23   mitochondrial ribosomal protein S23 
  tcav0004.l.02  rpl13   ribosomal protein L13 
  tcav0003.i.10  rps27  ribosomal protein S27 
  tcav0001.j.23  rps9_1   ribosomal protein S9 
  tcav0004.j.05  rps9_2   ribosomal protein S9 
8 2 tcad0005.o.16  mrpl15   mitochondrial ribosomal protein L15 
      tcad0005.h.20  rpl8_1   ribosomal protein L8 
9 1 tcac0006.g.18  rpl6   ribosomal protein L6 
10 3 tcac0001.c.07  rpl26   ribosomal protein L26 
  tcac0006.m.21  rplp0   ribosomal protein, large, P0 
      tcac0006.f.11  rps3  ribosomal protein S3 
11 1 tcac0002.i.15  rpl8_2   ribosomal protein L8 
12 2 tcab0002.b.17  rplp1   ribosomal protein, large, P1 
      tcab0002.f.23  rps8   ribosomal protein S8 
Females Females Males Males F.11 F.11β β KM N Clone name Gene Symbol Gene Name
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containing both genes known to be involved in testicular
differentiation (e.g. amh, sox9, dmrt1, gata4, lhx9) [18] and
some potential new players revealed by our analysis.
Interestingly the expression levels of all these genes are
not restored by the androgen masculinizing treatment,
and this could indicate that they are probably not neces-
sary for early testicular differentiation in rainbow trout.
Among the gene clusters specifically up-regulated in
females following masculinization with androgens, extra-
cellular matrix, muscle markers/cytoskeleton and meiosis
were characterized as the 3 main gene annotations. Simul-
taneous up-regulation of extracellular matrix protein
genes expression and down-regulation of matrix protein-
ase genes was detected in gonads of androgen-treated
females. At the same time the histological analysis of these
gonads showed that they contain a predominant stroma
of conjunctive tissue with fibroblast like cells. Matrix pro-
tein synthesis and the concomitant decrease in matrix pro-
teinase activity have been well described as a characteristic
fibrotic response of an excessive Transforming Growth
Factor-beta (TGFβ) production [18,19]. Of special interest
in that context is the up-regulation of transforming
growth factor-β1 (tgfb1) in gonads of androgen-treated
animals. In rat, TGFβ induced morphological changes in
Leydig cells, accompanied by an increased secretion of
fibronectin, laminin and collagen IV [20]. In fibroblasts
treated with TGFβ1 a similar over-expression of genes
Expression profiles of genes belonging to the Gene Ontology term "extracellular matrix" (ID 5578) Figure 6
Expression profiles of genes belonging to the Gene Ontology term "extracellular matrix" (ID 5578). Clones with 
similar gene names that belong to the same contig (ensemble of clones with overlapping sequences) but displayed very different 
expression profiles were excluded from the table (when the expression profiles were not too different the gene symbol are 
marked with an asterisk). Clones with similar gene names and belonging to different contigs were annotated as gene symbol_1 
and gene symbol_2 as they could be considered as potentially duplicated genes or differential splicing forms. The 15 different 
contigs with homologies to zona pellucida protein homologs (zp2, zp3 and zp4 genes that are highly represented in clusters 1 
to 5 have been removed from that table). KM: K-means cluster number. N: number of genes belonging to the GO term in the 
specified cluster.
1
3
5
6
7
9
10
11
12
13
Females Females Males Males F.11 F.11β β KM N Clone name
1 tcac0001.g.13  col1a2_1 
4 tcad0007.f.10  col1a1_1 
tcad0008.g.18  lgals3bp  
tcac0004.c.16  timp2_1  
 tcad0005.f.08 timp2_2  
1 tcad0008.p.06  timp2_3  
2 tcav0002.d.24  c7  
tcac0005.a.06  fbln1  
10 tcad0006.g.17  col1a1_2 
tcav0002.c.02  col1a1_3 
tcad0005.o.07  col1a2_2 
tcav0004.e.12  c6 
tcav0001.o.16  col6a2_1 
tcad0009.k.08  lum 
tcav0003.d.06  mfap2_1 
tcab0003.o.21  mmp2  
tcad0002.h.06  postn  
 tcad0009.e.24  sparc  
4 tcav0005.o.23  col6a2_2 
tcad0005.n.05  mfap2_2 
tcav0002.k.04  mfap2_3 
tcav0005.h.23  tgm2  
2 CA388477  lama5  
 tcav0005.f.22 Lamb2  
2 tcad0007.o.11  mmp13* 
tcav0004.b.01  tnc 
3 tcad0007.a.23  mmp13*  
tcad0006.h.11  mmp14  
 tcad0009.m.08  mmp19  
1 tcac0002.b.23  Col8a2  
collagen, type I, alpha 2 
collagen, type I, alpha 1  
lectin, galactoside-binding, soluble, 3 binding protein
tissue inhibitor of metalloproteinase 2 
tissue inhibitor of metalloproteinase 2 
tissue inhibitor of metalloproteinase 2 
complement component 7 
fibulin 1 
collagen, type I, alpha 1  
collagen, type I, alpha 1  
collagen, type I, alpha 2 
Complement component C6 
procollagen, type VI, alpha 2 
Lumican [Precursor] 
microfibrillar-associated protein 2 
matrix metalloproteinase 2 
periostin, osteoblast specific factor 
secreted acidic cysteine rich glycoprotein 
procollagen, type VI, alpha 2 
microfibrillar-associated protein 2 
microfibrillar-associated protein 2 
transglutaminase 2, C polypeptide 
laminin, alpha 5 
laminin, beta 2 
matrix metalloproteinase 13 
Tenascin-C 
matrix metalloproteinase 13 
matrix metalloproteinase 14  
matrix metalloproteinase 19 
procollagen, type VIII, alpha 2   
Gene Name Gene Symbol
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Expression profiles of some representative genes within the GO category: extracellular matrix (ID 5578) Figure 7
Expression profiles of some representative genes within the GO category: extracellular matrix (ID 5578). 
Expression profile values were extracted from the DNA microarray dataset and normalized to the highest signal value 
observed among all samples for each gene. This highest signal value was arbitrarily set at 100 and the resulting values are desig-
nated the relative signal intensity for the studied gene at the indicated time points. Expression profiles of transforming growth 
factor-beta1, tgfb1 (AJ007836) were obtained by real-time RT-PCR. tgm2: transglutaminase 2, C polypeptide. col1a1: collagen, 
type I, alpha 1. col1a2: collagen, type I, alpha 2. fbln1: fibulin 1. sparc: secreted acidic cysteine rich glycoprotein. mmp1a: matrix 
metalloproteinase 1a. mmp13: matrix metalloproteinase 13.
Males Males Females Females Androgen Androgen treated treated females femalesBMC Genomics 2007, 8:357 http://www.biomedcentral.com/1471-2164/8/357
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associated with matrix formation has been detected
including many different matrix protein genes, like
SPARC (Secreted Protein, Acidic and Rich in Cysteine),
MGP (matrix Gla protein), and TGFβ1 itself [21], that we
also detected as up-regulated in gonads following andro-
gen treatment. It could then be hypothesized that this late
androgen up-regulation of tgfb1 in trout gonads triggers a
fibrotic response. Surprisingly, these effects are detected
transiently and rather late after the application of the
androgen treatment (but concomitantly with tgfb1 up-reg-
ulation). Whether this reflects a total dysregulation or an
exacerbation of a testicular-specific event remains to be
analyzed. However, extracellular matrix deposition is
known as a major event for the testicular organization. For
instance, LAMA5 (Laminin α5) has been characterized as
a structural protein involved in the formation of the base-
ment membrane of the testicular cords [22] and this pro-
tein was found to be anti-correlated with Anti-Müllerian
Hormone (AMH) [23]. In trout gonads, amh expression is
not restored to male levels in androgen-treated females.
This may produce a disrupted expression of some struc-
tural proteins, like lama5. In the same manner, sparc is
highly up-regulated in androgen-treated females. In
mouse Sparc gene expression has been identified in pre-
Sertoli cells at the time of sex differentiation [24] and this
protein has also been postulated to play a crucial role in
both Leydig and Sertoli cells differentiation by affecting
their morphology [25]. Structural proteins including
matrix proteins are then of major importance for a com-
plete and functional testicular differentiation and their
up-regulation in trout following an androgen treatment
inducing testicular transdifferentiation may be the conse-
quence of a dysregulation of some major regulators of
their synthesis like amh or tgfb1.
Expression profiles of some representative genes from cluster 13 Figure 8
Expression profiles of some representative genes from cluster 13. Expression profile values were extracted from the 
DNA microarray dataset and normalized to the highest signal value observed among all samples for each gene. This highest sig-
nal value was arbitrarily set at 100 and the resulting values are designated the relative signal intensity for the studied gene at the 
indicated time points. angiopoietin-like 7 (angptl7, tcad0004.b.24 and tcac0004.n.11), gonadal soma-derived growth factor (gsdf, 
tcac0002.i.22), family with sequence similarity 49, member b (fam49b, tcac0003.e.03), claudin 12 (cldn12, tcad0009.h.07).
gsdfBMC Genomics 2007, 8:357 http://www.biomedcentral.com/1471-2164/8/357
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Table 3: Correlation between real-time RT-PCR and DNA microarray data
Gene symbol Gene name Mouse Human GenBank # rp KM
amh anti-müllerian hormone Amh AMH BX65284 13
tcav0004c.11 0.903 ***
star steroidogenic acute regulatory protein Star STAR A047032 13
tcad0007a.07 0.546 ***
tcad0008a.24 0.603 ***
dmrt1 doublesex- and mab-3-related transcription factor 1 Dmrt1 DMRT1 AF209095 9
tcad0009a.11 0.813 ***
nr5a1b nuclear receptor subfamily 5, group A, member 1 b Nr5a1 NR5A1 AY879314 11
tcad0006a.10 0.439 ***
apoeb apolipoprotein E b Apoe APOE
AJ132620 6
tcac0005c.15 0.634 ***
tcad0007a.20 0.695 ***
bzrp benzodiazepine receptor, peripheral Bzrp BZRP AY029216 9
tcab0001c.16 0.181 NS
bmp7 bone morphogenetic protein 7 Bmp7 BMP7 BX301016 3
tcav0001c.14 0.557 ***
gdf9 growth differentiation factor 9 Gdf9 GDF9 BX79301 3
tcad0007a.06 0.660 ***
inha inhibin alpha Inha INHA AB044566 6
tcav0001c.05 0.885 ***
tcav0005c.12 0.907 ***
tcac0005c.12 0.780 ***
tcad0005a.05 0.805 ***
gcl germ cell-less homolog (Drosophila) Gcl GCL BX081118 8
tcad0009a.22 0.417 ***
vldr very low density lipoprotein receptor Vldr VLDR AJ003117 3
tcad0005a.13 0.823 ***
hsp90b heat shock protein 90 beta Hspcb HSPCB BX072707 2
tcac0006c.15 0.628 ***
gapdh glyceraldehyde-3-phosphate dehydrogenase Gapdh GAPDH AF027130 1
tcab0001c.21 0.427 ***
tcac0004c.07 0.463 ***
tcac0006c.01 0.436 ***
tcad0002a.13 0.314 *
tfa transferrin Trf TF D89083 10
tcad0003a.22 0.053 NS
aldob aldolase b, fructose-bisphosphate Aldob ALDOB BX081681 3
tcad0001a.21 0.790 ***
m agoh mago-nashi homolog, proliferation-associated Magoh MAGOH BX080533 4
tcab0001c.07 0.812 ***
timp2 tissue inhibitor of metalloproteinase 2 Timp2 TIMP2 CA360907 9
tcac0004c.16 0.082 NS
tcad0001a.20 0.167 NS
tcad0005a.08 0.031 NS
tcad0006a.16 0.013 NS
tcad0007a.18 0.060 NS
tra2a transform er-2 alpha Tra2a TRA2A BX074515 5
tcad0008a.18 0.366 **
Each gene is depicted by its gene symbol and gene name (according to the zebrafish nomenclature). Symbols for mouse and human homolog genes 
are also given with their corresponding GenBank accession number. K-means cluster number (KM) is given for each gene with the correlation 
coefficient r to compare correlation between expression profiles measured by real-time RT-PCR (GenBank # in bold) and microarrays (clone 
numbers). Significant correlations were determined using the Pearson's correlation coefficient test (**: p < 0.01; ***: p < 0.05; NS: Not Significant).BMC Genomics 2007, 8:357 http://www.biomedcentral.com/1471-2164/8/357
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We also detected a high number of genes associated with
cytoskeletal reorganization and muscle development that
were up-regulated by the treatment. Some of them (e.g.
cnn1, myh11, myl6, tagln) are even considered as character-
istic smooth muscle markers. This expression of muscle
markers in the testis is likely in relation with the peritubu-
lar myoid cells that surround the seminiferous tubules
[26]. These myoid cells are known to express muscle
markers like for instance, tpm1 (tropomyosin 1, alpha) [27],
smooth muscle alpha-actin [28], and smooth muscle
myosin [29]. Differentiation of these cells is androgen
dependent [28] and they contribute to the testicular secre-
tion of extracellular matrix components [30] along with
the Sertoli cells [31]. It is therefore suggested that the mas-
culinizing androgen treatment may induce the differenti-
ation and subsequently a disturbed androgen-dependent
proliferation of these peritubular myoid cells. These cells
are also probably involved in the important extracellular
matrix synthesis that occurs concomitantly with this dif-
ferentiation.
In our experiment, the androgen treatment also induced a
precocious spermatogenesis as revealed both by the histo-
logical analysis and by the increased expression levels of
some genes involved in testicular meiosis. In fish, andro-
gens and particularly, 11-oxygenated androgens, are
strongly involved in spermatogenesis regulation [32] and
they have been shown to directly induce spermatogenesis
in vitro in some species [33]. Similarly, in mammals, three
independent studies using Sertoli cell-specific AR-knock-
out mice (mice knockout for the androgen receptor, AR)
demonstrated that the action of androgen is an absolute
requirement for the completion of spermatogenesis, par-
ticularly in the process of meiosis [34-36].
Scatterplots of DNA microarray and real-time RT-PCR measurements for inha (inhibin alpha), amh (anti-müllerian hormone),  star (Steroidogenic acute regulatory protein) and tf (transferrin) Figure 9
Scatterplots of DNA microarray and real-time RT-PCR measurements for inha (inhibin alpha), amh (anti-
müllerian hormone), star (Steroidogenic acute regulatory protein) and tf (transferrin). Each value is represented 
as the percentage of the highest value in each experiment (DNA microarray or real-time RT-PCR) in all experimental groups 
(red for females; blue for males; black for androgen-treated females). For each gene, the correlation coefficient R and colorized 
vectors of microarray and real-time RT-PCR values are given.
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Conclusion
This study gives a first comprehensive survey of gene
expression during androgen-induced masculinization in
female rainbow trout. Our data provide supportive evi-
dences that this treatment results in a marked dysregula-
tion of gene expression levels when compared to natural
testicular or ovarian differentiation. In our experimental
condition the androgen treatment induces the complete
down-regulation of female specific genes, but not the
complete restoration of the male-specific gene expression
patterns. Instead, some disturbed responses were charac-
terized by an exacerbation of extracellular matrix synthesis
and muscle type cell differentiation and proliferation
(myoid cells) followed by a precocious meiosis of germ
cells. All together, we suggest that androgen masculiniza-
tion acts mainly through an early inhibition of female
development rather than through a direct induction of
testicular differentiation.
Methods
Animals and samplings
Research involving animal experimentation has been
approved by the authors' institution (authorization no.
35-14). It conforms to principles for the use and care of
laboratory animals and is in compliance with French and
European regulations on animal welfare (European Con-
vention for the Protection of Vertebrate Animals Used for
Experimental and Other Scientific Purposes, ETS no. 123,
January 1991). All-male and all-female rainbow trout
populations were obtained at the INRA experimental fish
farm (Sizun, France) as previously described [37]. Treat-
ment with androgens (female treated Group 'F11β') was
carried out at the onset of the first feeding [Day 0 = D0 at
55 days post-fertilization (55 dpf)], on an all-female pop-
ulation. The androgen, 11β-hydroxyandrostenedione
(11βOH∆4, Sigma, St. Louis, MO, USA), was adminis-
tered by adding it to the food (10 mg/kg food) during 3
months starting from the first feeding and this treatment
has been shown to produce 100% sex-inversions [10]. In
each group, 20 to 100 gonads were sampled and pooled
in duplicates corresponding to the various stages of devel-
opment: onset of the free swimming period after complete
yolk resumption (Day 0 = D0), D0+7 days (D7), occur-
rence of oocyte meiosis (D12), beginning of ovarian
lamellar structures development (D27), occurrence of
previtellogenic oocytes (D60), D90 and D110. They were
immediately frozen in liquid nitrogen and stored at -80°C
until RNA extraction. Additional gonads were sampled at
the same time-points for histological analysis, which was
performed as previously described [38].
Total RNA extraction
Total RNA was extracted using TRIzol reagent (Invitrogen,
Cergy Pontoise, France) as previously described [39]. The
total RNA concentration was determined with an Agilent
2100 Bioanalyzer and the RNA 6000 LabChip® kit (Agilent
Technologies, Stockport, UK) according to the manufac-
turers' instructions.
DNA microarrays preparation
DNA Microarrays construction
Gene expression analyses were carried out using home-
made Nylon DNA microarrays using a previously
described technology [40]. These DNA microarrays were
built using as templates cDNA clones provided by the
INRA-AGENAE program [7]. All these clones were PCR-
amplified at the INRA Resources Centre for Animal
Genomics (CRB GADIE, Jouy en Josas, France) using
primers designed on the plasmid sequences flanking the
cDNA inserts (M13RP1 5'-GTGGAATTGTGAGCGGA-
TAAC and M13RP2 5'-GCAAGGCGATTAAGTTGGG). 35
cycles of PCR amplifications were carried out in 100 µl of
1× buffer containing 25 mM MgCl2, 250 µM dNTP, 100
µM of each primer, and 2.5 Units of Taq polymerase
(Promega, Madison, WI). For each cDNA clone, two 100
µl PCR reactions were pooled, desiccated and resus-
pended in 50 µl of distilled water. They were then spotted
as previously described [41] onto Hybond-N+ 2 × 7 cm2
membranes (Amersham Pharmacia Biotech, Cleveland,
OH, USA) attached to glass slides using an 8-pin print
head (Pin-and-Ring™ technology) on the GMS 417™
(Affymetrix, MWG-Biotech, Ebersberg, Germany). Spot-
ted DNA was then denatured and UV – cross-linked onto
nylon filters. All DNA microarrays used in this study were
made at the same time and under the same conditions.
These trout microarrays contained 9,216 DNA spots rep-
resenting 9,120 trout cDNA clones and a set of 96 con-
trols. Among these cDNA clones, 7,584 were issued from
a pooled-tissues library and 1,536 from a testis library [7].
Negative controls consisted of 80 spots of an Arabidopsis
thaliana cytochrome c554 clone which is devoid of simi-
larity with trout DNA sequences, 8 spots of poly(dA)80
and 8 spots of PCR reaction without template.
DNA microarray hybridizations
Microarrays were hybridized with two types of 33P-
labeled probes. The first one was an oligonucleotide with
a sequence common to all spotted PCR-products (vector
hybridization) in order to determine the amount of target
DNA accessible to hybridization in each spot. After strip-
ping, a second hybridization was performed with complex
probes made from 1 µg of retrotranscribed total RNA [40-
42]. Protocols for probes preparation, hybridizations and
washes are available online [43]. After stringent washes,
arrays were exposed to phosphor-imaging plates and
scanned with a FUJI BAS 5000 at 25 µm resolution.
Hybridization signals were quantified using ArrayGauge
software (Fuji Ltd, Tokyo, Japan).BMC Genomics 2007, 8:357 http://www.biomedcentral.com/1471-2164/8/357
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Real-time RT-PCR
In order to validate and enrich the DNA microarray data-
set, expression of 102 genes involved in early gonad devel-
opment [15] was measured by real-time reverse
transcription-polymerase chain reaction (RT-PCR). For
cDNA synthesis, 1 µg of total RNA was denatured in the
presence of random hexamers (0.5 µg) for 5 min at 70°C,
and then chilled on ice. Reverse transcription (RT) was
performed at 37°C for 1 h using M-MLV reverse tran-
scriptase (Promega, Madison, WI, USA) as described by
the manufacturer. Real-time PCR was carried out as previ-
ously described [15] using the iCycler iQTM (Bio-Rad,
Hercules, CA, USA) and the SYBER Green PCR master Mix
(Eurogentec, Seraing, Belgium). For each target gene, all
the samples were analyzed on the same plate in the same
PCR assay. PCR data were processed as previously
described, each transcript level being normalized by divi-
sion with the expression values of the constitutive elonga-
tion factor 1α ( ef1a), which was used as an internal
standard [15]. Data were then included in the microarray
data matrix for clustering analysis (see next paragraph).
Data analysis
First, non-linear effects such as background, print-tip
effects or saturation were corrected by LOWESS [44],
using a channel by channel procedure [45]. Each array was
individually normalized to the median profile of all
arrays. We used the print-tip LOWESS version imple-
mented in the statistical software package R [46]. Data
were further corrected for the amount of spotted cDNA.
This step is necessary as it has been shown that the signal
intensity is proportional to the amount of probe on the
surface of the array [40,47]. This effect can be observed
both for glass and Nylon surfaces. This effect is corrected
by the use of a reference in dual channel arrays, and by an
independent measurement of the spotted amount of DNA
probe in single channel arrays. On Nylon membranes,
this effect is linear and can be corrected by dividing the
signal by the amount of probe [40]. Briefly, sample signal
intensity of each spot ("S") was divided ("S/V") by the cor-
responding signal intensity of the same spot obtained
with the vector hybridization ("V"). To minimize experi-
mental differences between different complex probe
hybridizations, 'S/V' values from each hybridization were
divided by the corresponding median value of 'S/V'
(quantile normalization).
A triple filtering procedure was then applied to the micro-
array dataset. The first consisted of filtering background
signals due to low amount of spotted DNA. When a "V"
spot signal was too weak (vector signal < 3× vector local
background), the data of the corresponding cDNA clone
was discarded (missing data). The second filtering proce-
dure was applied to eliminate non informative genes that
were not measured (sample signal < 3× sample local back-
ground) in more than 20% of the samples. Finally, genes
exhibiting little variation (coefficient of variation < 0.1)
across all arrays were excluded from the analysis [48,49].
After these three filtering steps, 2,372 genes were retained
for further analysis.
All data (2372 microarray and 102 real-time RT-PCR gene
expression profiles) were then log2-transformed and were
analyzed by unsupervised and supervised clustering meth-
ods. Hierarchical clustering (Cluster program [50]) inves-
tigated the relationships between the genes and between
the samples by using centroid linkage clustering with
Pearson's uncentered correlation as similarity metric on
data that were median-centered on genes. Gene clusters
were distinguished using the non-hierarchical unsuper-
vised learning k-means algorithm implemented in the
Cluster program [50]. It was run on log2-transformed and
gene median-centered data with a maximum cycles
parameter of 100. The optimal minimal 'k' number of
clusters, corresponding to the stability of the k-means
clustering, was empirically set at 13. Indeed, with smaller
k numbers, some clusters merged together whereas with
greater k numbers, the size of some clusters decreased
(less than 50 genes to truly empty clusters). Results (color-
ized matrix) of hierarchical and k-means clustering analy-
ses were visualized using the Java TreeView program [51].
Functional annotation of genes was performed using
Gene Ontology [52] and the GoMiner program [53]. Sig-
nificance of over- or under-representation was calculated
using Fisher's exact test at 0.05% risk.
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